DRI-C21045 (DRI C21045)

2101765-81-3 Basic information More..

Product Name:	DRI-C21045 (DRI C21045)
Synonyms:	DRI-C21045 (DRI C21045);DRI C21045,Tumor Necrosis Factor Receptor,DRI-C21045,DRIC21045,Inhibitor,DRI-C-21045,TNFR,inhibit,TNF Receptor;Benzoic acid, 4-[[[4'-[[(8-sulfo-1-naphthalenyl)amino]carbonyl][1,1'-biphenyl]-4-yl]amino]carbonyl]-, 1-methyl ester;8-(4'-(4-(Methoxycarbonyl)benzamido)-[1,1'-biphenyl]-4-carboxamido)naphthalene-1-sulfonic acid;DRI-C21045
CAS:	2101765-81-3
MF:	C32H24N2O7S
MW:	580.61
EINECS:
Mol File:	2101765-81-3.mol

DRI-C21045 (DRI C21045) manufacturers

Information Error Report

Your Email:

Browse by province 2101765-81-3 Suppliers

2101765-81-3 Recommend Suppliers

Recommend You Select Member Companies

Company Name:	Shanghai EFE Biological Technology Co., Ltd. Recommend Complaint

Tel:	021-65675885 18964387627
Email:	info@efebio.com
Products Intro:	Product Name:DRI-C21045 CAS:2101765-81-3 Purity:98% Package:1mg;2mg;5mg
CB Index:	58
WebSite:	http://www.efebio.com
Related Information:	Sales Network Catalog(9799) User Evaluation

Company Name:	MQ (shanghai) Pharmaceuticals Co., Ltd. Recommend Complaint

Tel:	13761635123
Email:	sales@linyuepharm.com
Products Intro:	Product Name:DRI-C21045 (DRI C21045) CAS:2101765-81-3 Purity:＞95% Package:1G，5G
CB Index:	55
WebSite:	http://www.linyuepharm.com/
Related Information:	Sales Network Catalog(5731) User Evaluation(1)

Company Name:	Fan De(Beijing) Biotechnology Co., Ltd. Recommend Complaint

Tel:	15911056312
Email:	liming@bio-fount.com
Products Intro:	Product Name:DRI-C21045 (DRI C21045) CAS:2101765-81-3 Purity:97.0% Package:5mg
CB Index:	58
WebSite:	www.bio-fount.com
Related Information:	Sales Network Catalog(9718) User Evaluation

Company Name:	ChemeGen(Shanghai) Biotechnology Co.,Ltd. Recommend Complaint

Tel:	18818260767
Email:	sales@chemegen.com
Products Intro:	Product Name:DRI-C21045 CAS:2101765-81-3 Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
CB Index:	58
WebSite:	http://www.chemegen.com
Related Information:	Sales Network Catalog(11123) User Evaluation

Company Name:	Bide Pharmatech Ltd. Recommend Complaint

Tel:	400-1647117 13681763483
Email:	product02@bidepharm.com
Products Intro:	Product Name:8-(4'-(4-(Methoxycarbonyl)benzamido)-[1,1'-biphenyl]-4-carboxamido)naphthalene-1-sulfonic acid CAS:2101765-81-3 Purity:98% Package:1mg;5mg;10mg;50mg;100mg Remarks:BD01176059
CB Index:	58
WebSite:	https://www.bidepharm.com/
Related Information:	Sales Network Catalog(59929) User Evaluation

Company Name:	TargetMol Chemicals Inc. Recommend Complaint

Tel:	4008200310 15002144251
Email:	marketing@tsbiochem.com
Products Intro:	Product Name:DRI-C21045 CAS:2101765-81-3 Purity:98.10% Package:1removed
CB Index:	58
WebSite:	https://www.targetmol.cn/
Related Information:	Sales Network Catalog(24951) User Evaluation

Company Name:	Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. Recommend Complaint

Tel:	025-025-66113011 15955137747
Email:	cb5@aikonchem.com
Products Intro:	Product Name:DRI-C21045 (DRI C21045) CAS:2101765-81-3 Purity:95% Package:1g;5g;10g
CB Index:	58
WebSite:	http://www.aikonchem.com
Related Information:	Sales Network Catalog(10354) User Evaluation

Company Name:	Nanjing Shizhou Biology Technology Co.,Ltd Recommend Complaint

Tel:	025-85560043 15850508050
Email:	cindy.huang@synzest.com
Products Intro:	Product Name:DRI-C21045 CAS:2101765-81-3 Purity:98% Package:10mg 100mg
CB Index:	58
WebSite:	http://www.synzest.com
Related Information:	Sales Network Catalog(11975) User Evaluation

1 2 3

Tag: 2101765-81-3

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.